← Eichor
Study identifier: NCT05223608 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy

Condition: Solid Tumor, Adult  ·  Sponsor: Centre Oscar Lambret

PhaseNA
Planned participants651
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

ImmuCCo-1905 is a monocentric interventional study on patients treated by immunotherapy, which consist in establishment of a prospective clinic-biologic database over 5 years, associated with a biobank. This database will allow carrying out works aiming at assessing immunotherapy in real life situation.

This description comes directly from the study's public registry record.

Talk to the study team

Julien THERY  ·  +330320295918  ·  promotion@o-lambret.fr

Marjane BELMIMOUN  ·  +330320295918  ·  promotion@o-lambret.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Centre Oscar LambretLille, Hauts-de-France, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05223608